PRLX-8025

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePRLX-8025
Drug Alias Namebeta catenin inhibitors (Prolexys)Pair 4 seriesPRLX-2113PRLX-8025
ClassificationSmall molecules
Mechanisms of ActionCatenin beta 1 degraders
TargetsCatenin beta 1
Therapy Area/IndicationsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProlexys Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProlexys Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A